BiomX (NYSEAMERICAN:PHGE – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($1.10) per share for the quarter.
BiomX Trading Up 2.9 %
PHGE opened at $0.61 on Thursday. BiomX has a one year low of $0.48 and a one year high of $4.99. The company has a market cap of $11.06 million, a PE ratio of -0.19 and a beta of 1.27.
Wall Street Analyst Weigh In
Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 price objective on shares of BiomX in a research note on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- Manufacturing Stocks Investing
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
